You are here: Home / News & Events / News / FDA Recently Approved Two Orphan Drugs

FDA Recently Approved Two Orphan Drugs

FDA approved two new Orphan Drugs.

December 27, 2012-- FDA recently announced the approval of two new Orphan Drugs.

FDA has approved Gattex as a treatement for adults with short bowel syndrome who need additional nutrition through IV feeding. More >

FDA has approved Juxtapid  to reduce low-density lipoprotein (LDL) cholesterol, total cholesterol, apolipoprotein B, and non-high-density lipoprotein (non-HDL) cholesterol in patients with homozygous familial hypercholesterolemia (HoFH). More >

 
Copyright ©2014 NORD - National Organization for Rare Disorders, Inc. All rights reserved.
The following trademarks/registered service marks are owned by NORD: NORD, National Organization for Rare Disorders, the NORD logo, RareConnect. .